Biomaterial Database

Capecitabine-induced Leukoencephalopathy. 2019

Kenji Yoshimura, and Shinya Tokunaga, and Haruko Daga, and Manabu Inoue

Department of Neurology, Osaka City General Hospital, Japan.

UI	MeSH Term	Description	Entries
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D011355	Prodrugs	A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.	Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069287	Capecitabine	A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.	N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine,Xeloda
D000964	Antimetabolites, Antineoplastic	Antimetabolites that are useful in cancer chemotherapy.	Antineoplastic Antimetabolites
D056784	Leukoencephalopathies	Any of various diseases affecting the white matter of the central nervous system.	Childhood Ataxia with Diffuse Central Nervous System Hypomyelination,Leukoencephalopathy,Leukoencephalopathy with Vanishing White Matter,Vanishing White Matter Disease,CACH Syndrome,CACH VWM Syndrome,Childhood Ataxia with Central Nervous System Hypomyelination,Childhood Ataxia with Central Nervous System Hypomyelinization,Cree Leukoencephalopathy,Myelinosis Centralis Diffusa,Vanishing White Matter Leukodystrophy,White Matter Diseases,CACH Syndromes,CACH VWM Syndromes,Centralis Diffusa, Myelinosis,Cree Leukoencephalopathies,Diffusa, Myelinosis Centralis,Diffusas, Myelinosis Centralis,Leukoencephalopathy, Cree,Myelinosis Centralis Diffusas,Syndrome, CACH VWM,VWM Syndrome, CACH,White Matter Disease
D038524	Diffusion Magnetic Resonance Imaging	A diagnostic technique that incorporates the measurement of molecular diffusion (such as water or metabolites) for tissue assessment by MRI. The degree of molecular movement can be measured by changes of apparent diffusion coefficient (ADC) with time, as reflected by tissue microstructure. Diffusion MRI has been used to study BRAIN ISCHEMIA and tumor response to treatment.	Magnetic Resonance Imaging, Diffusion,Diffusion MRI,Diffusion Weighted MRI,Diffusion MRIs,MRI, Diffusion Weighted